The goal is long-term resilience and health span, not an instant transformation
The first is conflating injectable and topical dosing conventions applying an injectable milligram-target approach to a topical protocol that should use concentration-based formulation, or vice versa
Moreover, the data suggests that glutathione status could be a modifiable risk factor for Parkinsons disease, warranting future clinical trials on glutathione supplementation
In fact, circulating MOTS-c levels are shown to increase with exercise and, much like GHK-Cu and other endogenous peptides, natural levels of MOTS-c tend to decrease with age, and for this reason it has gained interest in the field of aging research
Journal of Parkinsons Disease , 7(2), 289299
D.BarthowC.MurphyR.et al